Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
NIAID Director Anthony Fauci said he's "cautiously optimistic" about a Moderna coronavirus vaccine that appeared to generate antibody responses to the virus in a small number of patients, at a CNN town hall on Thursday.
What he's saying: "Although the numbers were limited, it was quite good news because it reached and went over an important hurdle in the development of vaccines. That's the reason why I'm cautiously optimistic about it."
Catch up quick: Moderna released early data from its phase one trial with the vaccine on Monday. The vaccine did not appear to cause life-threatening side effects and was found to be "generally safe and well-tolerated" when used on eight healthy volunteers, Axios' Bob Herman reported earlier this week.
Go deeper: Moderna has a huge day after igniting hope for coronavirus cure